Stage IV bladder urothelial carcinoma ajcc V7
Clinical trials for Stage IV bladder urothelial carcinoma ajcc V7 explained in plain language.
Never miss a new study
Get alerted when new Stage IV bladder urothelial carcinoma ajcc V7 trials appear
Sign up with your email to follow new studies for Stage IV bladder urothelial carcinoma ajcc V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sea sponge compound tested against bladder cancer in patients with poor kidney function
Disease control OngoingResearchers are studying eribulin mesylate, a chemotherapy drug, in people with urothelial cancer that has spread or cannot be removed by surgery, and who also have kidney problems. The trial has two parts: one to find the highest dose patients can tolerate, and another to see ho…
Matched conditions: STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New drug targets genetic weakness in bladder cancer
Disease control OngoingThis phase 2 trial tests a drug called sapanisertib in 17 people with advanced bladder cancer that has a specific genetic change (TSC1 or TSC2 mutation). The drug works by blocking a protein that helps cancer cells grow. Researchers want to see if the drug can shrink tumors and h…
Matched conditions: STAGE IV BLADDER UROTHELIAL CARCINOMA AJCC V7
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC